Interdisciplinary Course of Science for Aging, Yonsei University, Seoul, South Korea.
Atherosclerosis. 2011 Jan;214(1):94-100. doi: 10.1016/j.atherosclerosis.2010.10.004. Epub 2010 Oct 30.
We investigated the association of polymorphisms in FADS genes with polyunsaturated fatty acids (PUFAs) in serum phospholipids, lipid peroxides, and coronary artery disease (CAD) in Koreans.
In this case-control study, CAD patients (n=756, 40-79 years) and healthy controls (n=890) were genotyped for rs174537 near FADS1 (FEN1 rs174537G>T), FADS2 (rs174575, rs2727270), and FADS3 (rs1000778). We calculated the odds ratios (ORs) for CAD risk and measured serum PUFA composition and lipid peroxide.
Among four SNPs, only rs174537G>T differed in allele frequencies between controls and CAD patients after adjustment for age, BMI, cigarette smoking, alcohol consumption, hypertension, diabetes mellitus, and hyperlipidemia (P=0.017). The minor T allele was associated with a lower risk of CAD [OR 0.75 (95%CI 0.61-0.92), P=0.006] after adjustment. rs174537T carriers had a significantly higher proportion of linoleic acid (LA, 18:2ω6), lower arachidonic acid (AA, 20:4ω6), and lower ratios of AA/dihomo-γ-linolenic acid (DGLA, 20:3ω6) and AA/LA than G/G subjects in both control and CAD groups. In the control group, 174537T carriers had significantly lower levels of total- and LDL-cholesterol, malondialdehyde, and ox-LDL. In CAD patients, rs174537T carriers showed a larger LDL particle size than G/G subjects. The proportion of AA in serum phospholipids positively correlated with LDL-cholesterol, ox-LDL, and malondialdehyde in controls and with 8-epi-prostaglandin F(2α) in both control and CAD groups.
The rs174537T is associated with a lower proportion of AA in serum phospholipids and reduced CAD risk, in association with reduced total- and LDL-cholesterol and lipid peroxides.
我们研究了 FADS 基因多态性与血清磷脂中多不饱和脂肪酸(PUFAs)、脂质过氧化物和冠状动脉疾病(CAD)在韩国人群中的相关性。
在这项病例对照研究中,对 756 例 40-79 岁的 CAD 患者和 890 例健康对照者进行了 FADS1(FEN1 rs174537G>T)、FADS2(rs174575、rs2727270)和 FADS3(rs1000778)附近的 rs174537G>T 多态性的基因分型。我们计算了 CAD 风险的比值比(OR),并测量了血清 PUFA 组成和脂质过氧化物。
在四个 SNP 中,只有 rs174537G>T 在调整年龄、BMI、吸烟、饮酒、高血压、糖尿病和高脂血症后,在对照组和 CAD 患者之间的等位基因频率不同(P=0.017)。T 等位基因与 CAD 风险降低相关[OR 0.75(95%CI 0.61-0.92),P=0.006]。rs174537T 携带者在控制组和 CAD 组中均具有较高的亚油酸(LA,18:2ω6)比例和较低的花生四烯酸(AA,20:4ω6)比例以及 AA/二高-γ-亚麻酸(DGLA,20:3ω6)和 AA/LA 比值。在对照组中,174537T 携带者的总胆固醇和 LDL 胆固醇、丙二醛和 ox-LDL 水平显著降低。在 CAD 患者中,与 G/G 患者相比,rs174537T 携带者的 LDL 颗粒更大。血清磷脂中 AA 的比例与对照组中的 LDL 胆固醇、ox-LDL 和丙二醛以及对照组和 CAD 组中的 8-epi-前列腺素 F(2α)呈正相关。
rs174537T 与血清磷脂中 AA 比例降低和 CAD 风险降低相关,与总胆固醇和 LDL 胆固醇以及脂质过氧化物降低相关。